Clinical Trial Update: Asacol Dosing Study for Active Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 dosing study of Asacol (mesalamine) for active ulcerative colitis has completed, according to the trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Asacol (mesalamine)

Snippet

Sponsor: University of Washington | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED